Attention bias modification task for Smoking

Phase-Based Progress Estimates
Attention bias modification task - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will examine whether a computerized attentional training procedure can reduce attentional bias towards smoking cues and reduce craving in regular cigarette smokers.

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Assessed at baseline and endpoint visits (one week apart)

Assessed at baseline and endpoint visits (one week apart)
Attentional Bias Scores
Brief Questionnaire of Smoking Urges (QSU-Brief)

Trial Safety

Trial Design

2 Treatment Groups

Active attention training condition
1 of 2
Control condition
1 of 2
Experimental Treatment
Non-Treatment Group

60 Total Participants · 2 Treatment Groups

Primary Treatment: Attention bias modification task · Has Placebo Group · N/A

Active attention training condition
Experimental Group · 1 Intervention: Attention bias modification task · Intervention Types: Behavioral
Control condition
PlaceboComparator Group · 1 Intervention: Control Condition · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: assessed at baseline and endpoint visits (one week apart)

Who is running the clinical trial?

Harvard UniversityOTHER
213 Previous Clinical Trials
18,228,502 Total Patients Enrolled
1 Trials studying Smoking
40 Patients Enrolled for Smoking
Boston UniversityLead Sponsor
414 Previous Clinical Trials
10,027,906 Total Patients Enrolled
Samantha Moshier, MAPrincipal InvestigatorBoston University

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are familiar with a computer keyboard and mouse.\n
You must own a phone or have regular access to the Internet.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: October 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
How old are they?
18 - 65100.0%
What site did they apply to?
Boston University100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%